Iain Chalmers - Net Worth and Insider Trading
Iain Chalmers Net Worth
The estimated net worth of Iain Chalmers is at least $1,638 dollars as of 2024-11-12. Iain Chalmers is the Director of Cardiol Therapeutics Inc and owns about 600 shares of Cardiol Therapeutics Inc (TSX:CRDL) stock worth over $1,638. Details can be seen in Iain Chalmers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Iain Chalmers has not made any transactions after 2019-10-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Iain Chalmers
Iain Chalmers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Iain Chalmers owns 1 companies in total, including Cardiol Therapeutics Inc (TSX:CRDL) .
Click here to see the complete history of Iain Chalmers’s form 4 insider trades.
Insider Ownership Summary of Iain Chalmers
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSX:CRDL | Cardiol Therapeutics Inc | 2019-10-17 | Director |
Iain Chalmers Latest Holdings Summary
Iain Chalmers currently owns a total of 1 stock. Iain Chalmers owns 600 shares of Cardiol Therapeutics Inc (TSX:CRDL) as of October 17, 2019, with a value of $1,638.
Latest Holdings of Iain Chalmers
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSX:CRDL | Cardiol Therapeutics Inc | 2019-10-17 | 600 | 2.73 | 1,638 |
Holding Weightings of Iain Chalmers
Iain Chalmers Form 4 Trading Tracker
According to the SEC Form 4 filings, Iain Chalmers has made a total of 0 transactions in Cardiol Therapeutics Inc (TSX:CRDL) over the past 5 years. The most-recent trade in Cardiol Therapeutics Inc is the acquisition of 600 shares on October 17, 2019, which cost Iain Chalmers around $1,950.
Insider Trading History of Iain Chalmers
- 1
Iain Chalmers Trading Performance
GuruFocus tracks the stock performance after each of Iain Chalmers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Iain Chalmers is 16.85%. GuruFocus also compares Iain Chalmers's trading performance to market benchmark return within the same time period. The performance of stocks bought by Iain Chalmers within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Iain Chalmers's insider trading performs compared to the benchmark.
Performance of Iain Chalmers
Iain Chalmers Ownership Network
Ownership Network List of Iain Chalmers
Ownership Network Relation of Iain Chalmers
Iain Chalmers Owned Company Details
What does Cardiol Therapeutics Inc do?
Who are the key executives at Cardiol Therapeutics Inc?
Iain Chalmers is the Director of Cardiol Therapeutics Inc. Other key executives at Cardiol Therapeutics Inc include Senior Officer Guillermo Torre , Director & Senior Officer David Elsley , and Director & Senior Officer Christopher James Waddick .
Cardiol Therapeutics Inc (TSX:CRDL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cardiol Therapeutics Inc (TSX:CRDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiol Therapeutics Inc Insider Transactions
Iain Chalmers Mailing Address
Above is the net worth, insider trading, and ownership report for Iain Chalmers. Currently GuruFocus does not have mailing address information for Iain Chalmers.